2023 Q2 Form 10-Q Financial Statement

#000147615023000007 Filed on May 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $79.54M $74.65M
YoY Change 21.67% 16.58%
Cost Of Revenue $18.59M $18.38M
YoY Change 17.6% 8.92%
Gross Profit $60.95M $56.27M
YoY Change 22.97% 19.32%
Gross Profit Margin 76.63% 75.38%
Selling, General & Admin $9.766M $9.320M
YoY Change 33.18% 23.82%
% of Gross Profit 16.02% 16.56%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $18.23M $18.16M
YoY Change 19.26% 21.21%
% of Gross Profit 29.91% 32.27%
Operating Expenses $28.00M $27.48M
YoY Change 23.77% 22.08%
Operating Profit $32.95M $28.79M
YoY Change 22.29% 16.8%
Interest Expense -$4.927M $7.375M
YoY Change -197.62% 45.15%
% of Operating Profit -14.95% 25.62%
Other Income/Expense, Net $7.330M -$5.412M
YoY Change -89.69% 9.11%
Pretax Income $40.25M $23.33M
YoY Change -58.52% 18.66%
Income Tax
% Of Pretax Income
Net Earnings $40.07M $23.33M
YoY Change -58.7% 18.66%
Net Earnings / Revenue 50.39% 31.25%
Basic Earnings Per Share $0.48 $0.29
Diluted Earnings Per Share $0.48 $0.29
COMMON SHARES
Basic Shares Outstanding 83.26M shares 76.98M shares
Diluted Shares Outstanding 83.12M shares 80.34M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $58.92M $11.05M
YoY Change 714.15% -89.6%
Cash & Equivalents $58.92M $11.05M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $58.92M $11.05M
YoY Change 718.33% -89.6%
LONG-TERM ASSETS
Property, Plant & Equipment $3.506B $3.472B
YoY Change 18.45% 27.51%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.101M $14.92M
YoY Change -64.44% -55.9%
Total Long-Term Assets $3.579B $3.567B
YoY Change 18.43% 26.77%
TOTAL ASSETS
Total Short-Term Assets $58.92M $11.05M
Total Long-Term Assets $3.579B $3.567B
Total Assets $3.637B $3.578B
YoY Change 20.09% 22.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $63.29M $52.02M
YoY Change 10.26% 18.78%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $129.0M $115.0M
YoY Change 17.7% 21.07%
LONG-TERM LIABILITIES
Long-Term Debt $771.1M $770.9M
YoY Change 5.2% 6.95%
Other Long-Term Liabilities $89.04M $92.54M
YoY Change 57.35% 84.4%
Total Long-Term Liabilities $860.2M $863.5M
YoY Change 8.93% 11.99%
TOTAL LIABILITIES
Total Short-Term Liabilities $129.0M $115.0M
Total Long-Term Liabilities $860.2M $863.5M
Total Liabilities $989.2M $978.5M
YoY Change 10.0% 12.98%
SHAREHOLDERS EQUITY
Retained Earnings $85.18M $78.39M
YoY Change 25.02% -2539.14%
Common Stock $2.595B $2.553B
YoY Change 24.27% 22.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.648B $2.600B
YoY Change
Total Liabilities & Shareholders Equity $3.637B $3.578B
YoY Change 20.09% 22.53%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $40.07M $23.33M
YoY Change -58.7% 18.66%
Depreciation, Depletion And Amortization $18.23M $18.16M
YoY Change 19.26% 21.21%
Cash From Operating Activities $48.56M $38.80M
YoY Change 37.98% 38.41%
INVESTING ACTIVITIES
Capital Expenditures $30.22M $22.77M
YoY Change -250.09% -179.09%
Acquisitions
YoY Change
Other Investing Activities $11.09M -$364.6M
YoY Change -110.87% 435.77%
Cash From Investing Activities -$19.13M -$387.4M
YoY Change -84.35% 300.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 16.92M $334.1M
YoY Change -239.13% -1362.2%
NET CHANGE
Cash From Operating Activities 48.56M $38.80M
Cash From Investing Activities -19.13M -$387.4M
Cash From Financing Activities 16.92M $334.1M
Net Change In Cash 46.36M -$14.42M
YoY Change -146.74% -84.86%
FREE CASH FLOW
Cash From Operating Activities $48.56M $38.80M
Capital Expenditures $30.22M $22.77M
Free Cash Flow $18.35M $16.04M
YoY Change -66.84% -71.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001476150
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
10500 NE 8th Street
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1910
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Bellevue
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
23331000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
19662000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
0 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
0 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
23331000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
19662000 usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-34603
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Terreno Realty Corporation
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-1262675
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
10500 NE 8th Street
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1910
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Bellevue
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98004
CY2023Q1 dei City Area Code
CityAreaCode
415
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
655-4580
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
CY2023Q1 dei Trading Symbol
TradingSymbol
TRNO
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
83258109 shares
CY2023Q1 us-gaap Land
Land
1930385000 usd
CY2022Q4 us-gaap Land
Land
1850860000 usd
CY2023Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
1491374000 usd
CY2022Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
1372473000 usd
CY2023Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
248146000 usd
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
51896000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
139814000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
123545000 usd
CY2023Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
3809719000 usd
CY2022Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
3398774000 usd
CY2023Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
337317000 usd
CY2022Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
323631000 usd
CY2023Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
3472402000 usd
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
3075143000 usd
CY2023Q1 us-gaap Real Estate Held For Development And Sale
RealEstateHeldForDevelopmentAndSale
12312000 usd
CY2022Q4 us-gaap Real Estate Held For Development And Sale
RealEstateHeldForDevelopmentAndSale
0 usd
CY2023Q1 us-gaap Real Estate Investments
RealEstateInvestments
3484714000 usd
CY2022Q4 us-gaap Real Estate Investments
RealEstateInvestments
3075143000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11054000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26393000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2605000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1690000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
79996000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
61215000 usd
CY2023Q1 us-gaap Assets
Assets
3578369000 usd
CY2022Q4 us-gaap Assets
Assets
3164441000 usd
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2023Q1 us-gaap Loans Payable
LoansPayable
198968000 usd
CY2022Q4 us-gaap Loans Payable
LoansPayable
198993000 usd
CY2023Q1 us-gaap Senior Notes
SeniorNotes
571973000 usd
CY2022Q4 us-gaap Senior Notes
SeniorNotes
571825000 usd
CY2023Q1 us-gaap Security Deposit Liability
SecurityDepositLiability
29791000 usd
CY2022Q4 us-gaap Security Deposit Liability
SecurityDepositLiability
27454000 usd
CY2023Q1 us-gaap Below Market Lease Net
BelowMarketLeaseNet
92535000 usd
CY2022Q4 us-gaap Below Market Lease Net
BelowMarketLeaseNet
55873000 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
33209000 usd
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
30753000 usd
CY2023Q1 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
52021000 usd
CY2022Q4 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
49692000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
978497000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
934590000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
82609838 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
76463482 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
827000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
765000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2552660000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2167276000 usd
CY2023Q1 us-gaap Common Stock Held In Trust
CommonStockHeldInTrust
32009000 usd
CY2022Q4 us-gaap Common Stock Held In Trust
CommonStockHeldInTrust
26462000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
78394000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
88272000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2599872000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2229851000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3578369000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3164441000 usd
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
74651000 usd
CY2022Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
64035000 usd
CY2023Q1 us-gaap Revenues
Revenues
74651000 usd
CY2022Q1 us-gaap Revenues
Revenues
64035000 usd
CY2023Q1 us-gaap Operating Lease Initial Direct Cost Expense Over Term
OperatingLeaseInitialDirectCostExpenseOverTerm
18381000 usd
CY2022Q1 us-gaap Operating Lease Initial Direct Cost Expense Over Term
OperatingLeaseInitialDirectCostExpenseOverTerm
16876000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
18159000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
14982000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9320000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7527000 usd
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
48000 usd
CY2022Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
28000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
45908000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
39413000 usd
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
1963000 usd
CY2022Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
121000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
7375000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
5081000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5412000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4960000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
23331000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
19662000 usd
CY2023Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
105000 usd
CY2022Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
81000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
23226000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
23226000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
19581000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
19581000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79895886 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75199529 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
80344742 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75284498 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
76463482 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2229851000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
23331000 usd
CY2023Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
943000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
377488000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
627000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3038000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
33209000 usd
CY2023Q1 trno Deposits To Deferred Compensation Plan
DepositsToDeferredCompensationPlan
0 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2599872000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2057963000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
19662000 usd
CY2022Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
493000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2829000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.34
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
25680000 usd
CY2022Q1 trno Deposits To Deferred Compensation Plan
DepositsToDeferredCompensationPlan
0 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
2054281000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
23331000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
19662000 usd
CY2023Q1 us-gaap Straight Line Rent
StraightLineRent
2173000 usd
CY2022Q1 us-gaap Straight Line Rent
StraightLineRent
2313000 usd
CY2023Q1 trno Amortization Of Lease Intangibles
AmortizationOfLeaseIntangibles
3541000 usd
CY2022Q1 trno Amortization Of Lease Intangibles
AmortizationOfLeaseIntangibles
3111000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
18159000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
14982000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
383000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
305000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3038000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2829000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3998000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2838000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3602000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1483000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
38801000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
28033000 usd
CY2023Q1 us-gaap Payments To Acquire Buildings
PaymentsToAcquireBuildings
364600000 usd
CY2022Q1 us-gaap Payments To Acquire Buildings
PaymentsToAcquireBuildings
68052000 usd
CY2023Q1 us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
8904000 usd
CY2022Q1 us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
10155000 usd
CY2023Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
13862000 usd
CY2022Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
18630000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-387366000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-96837000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
366499000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2023Q1 trno Issuance Costs On Issuance Of Common Stock
IssuanceCostsOnIssuanceOfCommonStock
978000 usd
CY2022Q1 trno Issuance Costs On Issuance Of Common Stock
IssuanceCostsOnIssuanceOfCommonStock
0 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
627000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
493000 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
29000000 usd
CY2022Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
29000000 usd
CY2022Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 usd
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 usd
CY2022Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
362000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
30753000 usd
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
25618000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
334141000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-26473000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-14424000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-95277000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28083000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
204801000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13659000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
109524000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
8381000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
7176000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
17219000 usd
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
18794000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-95277000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
770941000 usd
CY2023Q1 us-gaap Stock Issued1
StockIssued1
5547000 usd
CY2022Q1 us-gaap Stock Issued1
StockIssued1
11535000 usd
CY2023Q1 trno Reconciliation Acquisition Of Properties
ReconciliationAcquisitionOfProperties
406730000 usd
CY2022Q1 trno Reconciliation Acquisition Of Properties
ReconciliationAcquisitionOfProperties
70295000 usd
CY2023Q1 trno Assumptions Of Other Assets And Liabilities
AssumptionsOfOtherAssetsAndLiabilities
42130000 usd
CY2022Q1 trno Assumptions Of Other Assets And Liabilities
AssumptionsOfOtherAssetsAndLiabilities
2243000 usd
CY2023Q1 us-gaap Payments To Acquire Buildings
PaymentsToAcquireBuildings
364600000 usd
CY2022Q1 us-gaap Payments To Acquire Buildings
PaymentsToAcquireBuildings
68052000 usd
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
6 segment
CY2022Q1 us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
3100000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P6Y6M
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates.</span>
CY2023Q1 us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
3500000 usd
CY2023Q1 us-gaap Below Market Lease Gross
BelowMarketLeaseGross
135844000 usd
CY2023Q1 us-gaap Below Market Lease Accumulated Amortization
BelowMarketLeaseAccumulatedAmortization
43309000 usd
CY2023Q1 us-gaap Below Market Lease Net
BelowMarketLeaseNet
92535000 usd
CY2022Q4 us-gaap Below Market Lease Gross
BelowMarketLeaseGross
95638000 usd
CY2022Q4 us-gaap Below Market Lease Accumulated Amortization
BelowMarketLeaseAccumulatedAmortization
39765000 usd
CY2022Q4 us-gaap Below Market Lease Net
BelowMarketLeaseNet
55873000 usd
CY2023Q1 trno Finite Lived Intangible Assets Liabilities Gross
FiniteLivedIntangibleAssetsLiabilitiesGross
5433000 usd
CY2023Q1 trno Finite Lived Intangible Assets Liabilities Accumulated Amortization
FiniteLivedIntangibleAssetsLiabilitiesAccumulatedAmortization
47028000 usd
CY2023Q1 trno Finite Lived Intangible Assets Liabilities Net
FiniteLivedIntangibleAssetsLiabilitiesNet
-41595000 usd
CY2022Q4 trno Finite Lived Intangible Assets Liabilities Gross
FiniteLivedIntangibleAssetsLiabilitiesGross
27907000 usd
CY2022Q4 trno Finite Lived Intangible Assets Liabilities Accumulated Amortization
FiniteLivedIntangibleAssetsLiabilitiesAccumulatedAmortization
47015000 usd
CY2022Q4 trno Finite Lived Intangible Assets Liabilities Net
FiniteLivedIntangibleAssetsLiabilitiesNet
-19108000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26393000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
204404000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1690000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
397000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28083000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
204801000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11054000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
106278000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2605000 usd
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3246000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13659000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
109524000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-14424000 usd
CY2023Q1 trno Straight Line Rent And Accounts Receivables Net Of Allowances
StraightLineRentAndAccountsReceivablesNetOfAllowances
62600000 usd
CY2022Q4 trno Straight Line Rent And Accounts Receivables Net Of Allowances
StraightLineRentAndAccountsReceivablesNetOfAllowances
48000000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
400000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
600000 usd
CY2023Q1 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
12300000 usd
CY2022Q4 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
11900000 usd
CY2023Q1 trno Share Based Compensation Performance Measurement Period
ShareBasedCompensationPerformanceMeasurementPeriod
P3Y
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
770818000 usd
CY2022Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
700000 usd
CY2023Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
700000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
775000000 usd
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
775000000 usd
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
775000000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
775000000 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
4059000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
4182000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
100000000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
50000000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
150000000 usd
CY2023Q1 trno Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
475000000 usd
CY2023Q1 trno Long Term Debt Before Net Debt Issuance Costs
LongTermDebtBeforeNetDebtIssuanceCosts
775000000 usd
CY2023Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
4059000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
770941000 usd
CY2023Q1 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.039
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
172949000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
221382000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
198688000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
166041000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
122299000 usd
CY2023Q1 trno Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
271727000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1153086000 usd
CY2023Q1 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
710422000 usd
CY2023Q1 us-gaap Notes Payable
NotesPayable
770941000 usd
CY2022Q4 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
700926000 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
770818000 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
3000000 shares
CY2022Q1 trno Stock Withdrawn During Period From Deferred Compensation Plan
StockWithdrawnDuringPeriodFromDeferredCompensationPlan
0 shares
CY2023Q1 trno Stock Withdrawn During Period From Deferred Compensation Plan
StockWithdrawnDuringPeriodFromDeferredCompensationPlan
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
377909 shares
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
CY2023Q1 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
373985 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
303666 shares

Files In Submission

Name View Source Status
0001476150-23-000007-index-headers.html Edgar Link pending
0001476150-23-000007-index.html Edgar Link pending
0001476150-23-000007.txt Edgar Link pending
0001476150-23-000007-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
trno-20230331.htm Edgar Link pending
trno-20230331.xsd Edgar Link pending
trnoq12023ex-311.htm Edgar Link pending
trnoq12023ex-312.htm Edgar Link pending
trnoq12023ex-313.htm Edgar Link pending
trnoq12023ex-321.htm Edgar Link pending
trnoq12023ex-322.htm Edgar Link pending
trnoq12023ex-323.htm Edgar Link pending
trno-20230331_def.xml Edgar Link unprocessable
trno-20230331_cal.xml Edgar Link unprocessable
trno-20230331_lab.xml Edgar Link unprocessable
trno-20230331_pre.xml Edgar Link unprocessable
trno-20230331_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable